Inflammation in intervertebral disc degeneration and regeneration

Journal of the Royal Society Interface

Volumn 12, Issue 104, 2015, Pages

  Molinos, Maria ^a,b   Almeida, Catarina R ^a   Caldeira, Joana ^a,b   Cunha, Carla ^a   Gonçalves, Raquel M ^a   Barbosa, Mário A ^a,b  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Degenerative disc disease; Inflammation; Intervertebral disc; Intervertebral disc homeostasis; Regeneration

Indexed keywords

MEDICAL PROBLEMS; MOBILE SECURITY; PATHOLOGY; PHYSIOLOGY; REPAIR; TISSUE;

CELLULAR INTERACTION; DEGENERATIVE DISC DISEASE; EXTRACELLULAR MATRICES; INFLAMMATION; INFLAMMATORY RESPONSE; INTER-VERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISCS; REGENERATION;

TISSUE HOMEOSTASIS;

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; CYTOKINE; LIGAND;

BONE REGENERATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISKITIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERVERTEBRAL DISC REGENERATION; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; NONVIRAL GENE THERAPY; REVIEW; ANIMAL; GENE THERAPY; HOMEOSTASIS; INFLAMMATION; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION;

ANIMALIA;

ANIMALS; CYTOKINES; GENETIC THERAPY; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERVERTEBRAL DISC DEGENERATION; LIGANDS; REGENERATION; RESEARCH DESIGN;

EID: 84923260818     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2014.1191     Document Type: Review

References (228)

1. Andersson GB. 1999 Epidemiological features of chronic low-back pain. Lancet 354, 581-585. (doi:10. 1016/S0140-6736(99)01312-4)
2. Schwarzer AC, Aprill CN, Derby R, Fortin J, Kine G, Bogduk N. 1995 The prevalence and clinical features of internal disc disruption in patients with chronic low back pain. Spine (Phila Pa 1976) 20, 1878-1883. (doi:10. 1097/00007632-199509000-00007)
3. Koes BW, Van Tulder MW, Peul WC. 2007 Diagnosis and treatment of sciatica. Br. Med. J. 334, 1313-1317. (doi:10. 1136/bmj. 39223. 428495. BE)
4. Hughes SP, Freemont AJ, Hukins DW, Mcgregor AH, Roberts S. 2012 The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J. Bone Joint Surg. Br. 94, 1298-1304. (doi:10. 1302/0301-620X. 94B10. 28986)
5. Santos SG et al. 2013 Adsorbed fibrinogen leads to improved bone regeneration and correlates with differences in the systemic immune response. Acta Biomater. 9, 7209-7217. (doi:10. 1016/j. actbio. 2013. 04. 008)
6. Sun Z, Zhang M, Zhao XH, Zhao ZH, GAO Y, Samartziz D, Wang HQ, Luo ZJ. 2013 Immune cascades in human intervertebral disc: the pros and cons. Int. J. Clin. Exp. Pathol. 6, 1009-1014.
7. Medzhitov R. 2008 Origin and physiological roles of inflammation. Nature 454, 428-435. (doi:10. 1038/ nature07201)
8. Urban JP, Smith S, Fairbank JC. 2004 Nutrition of the intervertebral disc. Spine (Phila Pa 1976) 29, 2700-2709. (doi:10. 1097/01. brs. 0000146499. 97948. 52)
9. Moore RJ. 2006 The vertebral endplate: disc degeneration, disc regeneration. Eur. Spine J. 15(Suppl. 3), S333-S337. (doi:10. 1007/s00586-006-0170-4)
10. Benneker LM, Heini PF, Alini M, Anderson SE, Ito K. 2005 2004 Young Investigator Award winner: vertebral endplate marrow contact channel occlusions and intervertebral disc degeneration. Spine (Phila Pa 1976) 30, 167-173. (doi:10. 1097/ 01. brs. 0000150833. 93248. 09)
11. Adams MA, Roughley PJ. 2006 What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 31, 2151-2161. (doi:10. 1097/01. brs. 0000231761. 73859. 2c)
12. Battie MC, Videman T, Kaprio J, Gibbons LE, Gill K, Manninen H, Saarela J, Peltonen L. 2009 The Twin Spine Study: contributions to a changing view of disc degeneration. Spine J. 9, 47-59. (doi:10. 1016/ j. spinee. 2008. 11. 011)
13. Cook CE, Taylor J, Wright A, Milosavljevic S, Goode A, Whitford M. 2013 Risk factors for first time incidence sciatica: a systematic review. Physiother. Res. Int. 19, 65-78. (doi:10. 1002/pri. 1572)
14. Cheung KM, Karppinen J, Chan D, Ho DWH, Song Y-Q, Sham P, Cheah KSE, Leong JCY, Luk KDK. 2009 Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 34, 934-940. (doi:10. 1097/BRS. 0b013e3181a01b3f)
15. Hristova GI, Jarzem P, Ouellet JA, Roughley PJ, Epure LM, Antoniou J, Mwale F. 2011 Calcification in human intervertebral disc degeneration and scoliosis. J. Orthop. Res. 29, 1888-1895. (doi:10. 1002/jor. 21456)
16. Desanto J, Ross JS. 2011 Spine infection/ inflammation. Radiol. Clin. N. Am. 49, 105-127. (doi:10. 1016/j. rcl. 2010. 07. 018)
17. Burke JG, Watson RW, Mccormack D, Dowling FE, Walsh MG, Fitzpatrick JM. 2002 Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J. Bone Joint Surg. Br. 84, 196-201. (doi:10. 1302/0301-620X. 84B2. 12511)
18. Lee RS, Kayser MV, Ali SY. 2006 Calcium phosphate microcrystal deposition in the human intervertebral disc. J. Anat. 208, 13-19. (doi:10. 1111/j. 1469-7580. 2006. 00504. x)
19. Gruber HE, Norton HJ, Sun YB, Hanley EN. 2007 Crystal deposits in the human intervertebral disc: implications. Spine J. 7, 444-450. (doi:10. 1016/j. spinee. 2006. 08. 015)
20. Feinberg J, Boachie-Adjei O, Bullough PG, Boskey AL. 1990 The distribution of calcific deposits in intervertebral discs of the lumbosacral spine. Clin. Orthop. Relat. Res. 254, 303-310.
21. Kalya S, Rosenthal AK. 2005 Extracellular matrix changes regulate calcium crystal formation in articular cartilage. Curr. Opin. Rheumatol. 17, 325-329. (doi:10. 1097/01. bor. 0000160783. 14798. 10)
22. Masuda I, Ishikawa K, Usuku G. 1991 A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease. Clin. Orthop. Relat. Res. 263, 272-287.
23. Stutz A, Golenbock DT, Latz E. 2009 Inflammasomes: too big to miss. J. Clin. Investig. 119, 3502-3511. (doi:10. 1172/JCI40599)
24. Weiler C, Nerlich AG, Bachmeier BE, Boos N. 2005 Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine (Phila Pa 1976) 30, 44-53; discussion 54. (doi:10. 1097/01. brs. 0000174529. 07959. c0)
25. Noble PW. 2002 Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21, 25-29. (doi:10. 1016/S0945-053X(01)00184-6)
26. Vaday GG, Lider O. 2000 Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J. Leukoc. Biol. 67, 149-159.
27. Eyre DR, Muir H. 1977 Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. Biochim. Biophys. Acta 492, 29-42. (doi:10. 1016/0005-2795(77)90211-2)
28. Eyre DR, Dickson IR, Van Ness K. 1988 Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. Biochem. J. 252, 495-500.
29. Sivan SS, Hayes AJ, Wachtel E, Caterson B, Merkher Y, Maroudas A, Brown S, Roberts S. 2014 Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc. Eur. Spine J. 23(Suppl. 3), S344-S353. (doi:10. 1007/s00586-013-2767-8)
30. Eyre DR, Muir H. 1976 Types I and II collagens in intervertebral disc. Interchanging radial distributions in annulus fibrosus. Biochem. J. 157, 267-270.
31. Brinckmann J, Notbohm H, Müller PK. 2005 Collagen: primer in structure, processing and assembly, vol. 247, p. 252. Berlin, Germany: Springer.
32. Ippolito E, Ponseti IV. 1981 Juvenile kyphosis: histological and histochemical studies. J. Bone Joint Surg. Am. 63, 175-182.
33. Gruber HE, Ingram JA, Hanley Jr EN. 2007 Morphologic complexity of the pericellular matrix in the annulus of the human intervertebral disc. Biotech. Histochem. 82, 217-225. (doi:10. 1080/ 10520290701713999)
34. Roberts S, Menage J, Duance V, Wotton SF. 1991 Type III collagen in the intervertebral disc. Histochem. J. 23, 503-508. (doi:10. 1007/ BF01041176)
35. Culav EM, Clark CH, Merrilees MJ. 1999 Connective tissues: matrix composition and its relevance to physical therapy. Phys. Ther. 79, 308-319.
36. Clouet J et al. 2009 Identification of phenotypic discriminating markers for intervertebral disc cells and articular chondrocytes. Rheumatology 48, 1447-1450. (doi:10. 1093/rheumatology/kep262)
37. Tow BP, Hsu WK, Wang JC. 2007 Disc regeneration: a glimpse of the future. Clin. Neurosurg. 54, 122-128.
38. Mio F et al. 2007 A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation. Am. J. Hum. Genet. 81, 1271-1277. (doi:10. 1086/522377)
39. Roberts S, Ayad S, Menage PJ. 1991 Immunolocalisation of type VI collagen in the intervertebral disc. Ann. Rheum. Dis. 50, 787-791. (doi:10. 1136/ard. 50. 11. 787)
40. Melrose J, Smith SM, Appleyard RC, Little CB. 2008 Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur. Spine J. 17, 314-324. (doi:10. 1007/s00586-007-0538-0)
41. Eyre DR, Wu JJ, Fernandes RJ, Pietka TA, Weis MA. 2002 Recent developments in cartilage research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem. Soc. Trans. 30, 893-899. (doi:10. 1042/BST0300893)
42. Brinckmann J et al. 2005 Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol. 24, 459-468. (doi:10. 1016/j. matbio. 2005. 07. 002)
43. Eyre DR, Matsui Y, Wu JJ. 2002 Collagen polymorphisms of the intervertebral disc. Biochem. Soc. Trans. 30, 844-848. (doi:10. 1042/ BST0300844)
44. Onnerfjord P, Khabut A, Reinholt FP, Svensson O, Heinegard D. 2012 Quantitative proteomic analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between subgroups. J. Biol. Chem. 287, 18 913-18 924. (doi:10. 1074/jbc. M111. 298968)
45. Johnson WE, Caterson B, Eisenstein SM, Roberts S. 2005 Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine (Phila Pa 1976) 30, 1139-1147. (doi:10. 1097/01. brs. 0000162624. 95262. 73)
46. Gotz W, Barnert S, Bertagnoli R, Miosge N, Kresse H, Herken R. 1997 Immunohistochemical localization of the small proteoglycans decorin and biglycan in human intervertebral discs. Cell Tissue Res. 289, 185-190. (doi:10. 1007/s004410050864)
47. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E. 1994 Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302, 527-534.
48. Reed CC, Iozzo RV. 2002 The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 19, 249-255. (doi:10. 1023/ A:1025383913444)
49. Gruber HE, Ingram JA, Hoelscher GL, Zinchenko N, Hanley Jr EN, Sun Y. 2009 Asporin, a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc. Arthritis Res. Ther. 11, R47. (doi:10. 1186/ar2660)
50. Kizawa H et al. 2005 An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat. Genet. 37, 138-144. (doi:10. 1038/ng1496)
51. Chakravarti S. 2002 Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj. J. 19, 287-293. (doi:10. 1023/ A:1025348417078)
52. Bengtsson E, Morgelin M, Sasaki T, Timpl R, Heinegard D, Aspberg A. 2002 The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem. 277, 15 061-15 068. (doi:10. 1074/ jbc. M108285200)
53. Haglund L, Ouellet J, Roughley P. 2009 Variation in chondroadherin abundance and fragmentation in the human scoliotic disc. Spine (Phila Pa 1976) 34, 1513-1518. (doi:10. 1097/BRS. 0b013e318 1a8d001)
54. Akhatib B, Onnerfjord P, Gawri R, Ouellet J, Jarzem P, Heinegard D, Mort J, Roughley P, Haglund L. 2013 Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging. J. Biol. Chem. 288, 19 280-19 287. (doi:10. 1074/ jbc. M112. 443010)
55. Melrose J, Smith S, Ghosh P, Whitelock J. 2003 Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine. J. Histochem. Cytochem. 51, 1331-1341. (doi:10. 1177/002215540305101010)
56. Oegema Jr TR, Johnson SL, Aguiar DJ, Ogilvie JW. 2000 Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine 25, 2742-2747. (doi:10. 1097/00007632-200011010-00005)
57. Kadler KE, Hill A, Canty-Laird EG. 2008 Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr. Opin. Cell Biol. 20, 495-501. (doi:10. 1016/j. ceb. 2008. 06. 008)
58. Leiss M, Beckmann K, Giros A, Costell M, Fassler R. 2008 The role of integrin binding sites in fibronectin matrix assembly in vivo. Curr. Opin. Cell Biol. 20, 502-507. (doi:10. 1016/j. ceb. 2008. 06. 001)
59. Yu J, Fairbank JC, Roberts S, Urban JP. 2005 The elastic fiber network of the anulus fibrosus of the normal and scoliotic human intervertebral disc. Spine (Phila Pa 1976) 30, 1815-1820. (doi:10. 1097/01. brs. 0000173899. 97415. 5b)
60. Yu J, Winlove PC, Roberts S, Urban JP. 2002 Elastic fibre organization in the intervertebral discs of the bovine tail. J. Anat. 201, 465-475. (doi:10. 1046/j. 1469-7580. 2002. 00111. x)
61. Johnson EF, Chetty K, Moore IM, Stewart A, Jones W. 1982 The distribution and arrangement of elastic fibres in the intervertebral disc of the adult human. J. Anat. 135, 301-309.
62. Ishii Y, Thomas AO, Guo XE, Hung CT, Chen FH. 2006 Localization and distribution of cartilage oligomeric matrix protein in the rat intervertebral disc. Spine (Phila Pa 1976) 31, 1539-1546. (doi:10. 1097/01. brs. 0000221994. 61882. 4a)
63. Rutges J, Creemers LB, Dhert W, Milz S, Sakai D, Mochida J, Alini M, Grad S. 2010 Variations in gene and protein expression in human nucleus pulposus in comparison with annulus fibrosus and cartilage cells: potential associations with aging and degeneration. Osteoarthritis Cartilage 18, 416-423. (doi:10. 1016/j. joca. 2009. 09. 009)
64. Gruber HE, Bornstein P, Sage EH, Ingram JA, Zinchenko N, Norton HJ, Hanley EN. 2008 Disruption of the thrombospondin-2 gene alters the lamellar morphology but does not permit vascularization of the adult mouse lumbar disc. Arthritis Res. Ther. 10, R96. (doi:10. 1186/ar2483)
65. Dicesare PE, Morgelin M, Mann K, Paulsson M. 1994 Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur. J. Biochem. 223, 927-937. (doi:10. 1111/j. 1432-1033. 1994. tb19070. x)
66. Le Maitre CL, Freemont AJ, Hoyland JA. 2004 Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J. Pathol. 204, 47-54. (doi:10. 1002/ path. 1608)
67. Vo NV, Hartman RA, Yurube T, Jacobs LJ, Sowa GA, Kang JD. 2013 Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. Spine J. 13, 331-341. (doi:10. 1016/j. spinee. 2012. 02. 027)
68. Weiler C, Nerlich AG, Zipperer J, Bachmeier BE, Boos N. 2002 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur. Spine J. 11, 308-320. (doi:10. 1007/ s00586-002-0472-0)
69. Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, Freemont AJ, Hoyland JA. 2009 Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum. 60, 482-491. (doi:10. 1002/art. 24291)
70. Nagase H. 2012 The ADAMTS family of metalloproteinases. In Extracellular matrix: pathobiology and signalling (ed. N Karamanos). Berlin, Germany: De Gruyter.
71. Richardson SM, Doyle P, Minogue BM, Gnanalingham K, Hoyland JA. 2009 Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res. Ther. 11, R126. (doi:10. 1186/ar2793)
72. Le Maitre CL, Freemont AJ, Hoyland JA. 2006 Human disc degeneration is associated with increased MMP 7 expression. Biotech. Histochem. 81, 125-131. (doi:10. 1080/10520290601005298)
73. Gruber HE, Ingram JA, Hanley Jr EN. 2005 Immunolocalization of MMP-19 in the human intervertebral disc: implications for disc aging and degeneration. Biotech. Histochem. 80, 157-162. (doi:10. 1080/10520290500387607)
74. Feng H, Danfelter M, Stromqvist B, Heinegard D. 2006 Extracellular matrix in disc degeneration. J. Bone Joint Surg. Am. 88(Suppl. 2), 25-29. (doi:10. 2106/JBJS. E. 01341)
75. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM. 2000 Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976) 25, 3005-3013. (doi:10. 1097/00007632-200012010-00007)
76. Roughley PJ. 2004 Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine (Phila Pa 1976) 29, 2691-2699. (doi:10. 1097/01. brs. 0000146101. 53784. b1)
77. Marom B, Rahat MA, Lahat N, Weiss-Cerem L, Kinarty A, Bitterman H. 2007 Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9. J. Leukoc. Biol. 81, 1466-1476. (doi:10. 1189/jlb. 0506328)
78. Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ. 1999 Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem. J. 339, 571-577. (doi:10. 1042/0264-6021:3390571)
79. Arroyo AG, Iruela-Arispe ML. 2010 Extracellular matrix, inflammation, and the angiogenic response. Cardiovasc. Res. 86, 226-235. (doi:10. 1093/cvr/ cvq049)
80. Virri J, Sikk S, Gronblad M, Tolonen J, Seitsalo S, Kankare J, Karaharju EO. 1994 Concomitant immunocytochemical study of macrophage cells and blood vessels in disc herniation tissue. Eur. Spine J. 3, 336-341. (doi:10. 1007/BF02200147)
81. Jiang D, Liang J, Noble PW. 2007 Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 23, 435-461. (doi:10. 1146/annurev. cellbio. 23. 090506. 123337)
82. Morwood SR, Nicholson LB. 2006 Modulation of the immune response by extracellular matrix proteins. Arch. Immunol. Ther. Exp. 54, 367-374. (doi:10. 1007/s00005-006-0043-x)
83. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TRDJ, Matera G, Popa C, van der Meer JWM, Netea MG, van den Berg WB. 2007 Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 56, 2957-2967. (doi:10. 1002/art. 22848)
84. Quero L et al. 2013 Hyaluronic acid fragments enhance the inflammatory and catabolic response in human intervertebral disc cells through modulation of toll-like receptor 2 signaling pathways. Arthritis Res. Ther. 15, R94. (doi:10. 1186/ar4274)
85. Sorokin L. 2010 The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 10, 712-723. (doi:10. 1038/nri2852)
86. Jones P, Gardner L, Menage J, Williams GT, Roberts S. 2008 Intervertebral disc cells as competent phagocytes in vitro: implications for cell death in disc degeneration. Arthritis Res. Ther. 10, R86. (doi:10. 1186/ar2466)
87. Nerlich AG, Weiler C, Zipperer J, Narozny M, Boos N. 2002 Immunolocalization of phagocytic cells in normal and degenerated intervertebral discs. Spine 27, 2484-2490. (doi:10. 1097/00007632-200211150-00012)
88. Phillips KL, Chiverton N, Michael AL, Cole AA, Breakwell LM, Haddock G, Bunning RAD, Cross AK, Le Maitre CL. 2013 The cytokine and chemokine expression profile of nucleus pulposus cells: implications for degeneration and regeneration of the intervertebral disc. Arthritis Res. Ther. 15, R213. (doi:10. 1186/ar4408)
89. Gabr MA et al. 2011 Interleukin-17 synergizes with IFNgamma or TNFalpha to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J. Orthop. Res. 29, 1-7. (doi:10. 1002/jor. 21206)
90. Huang KY, Lin RM, Chen WY, Lee CL, Yan JJ, Chang MS. 2008 IL-20 may contribute to the pathogenesis of human intervertebral disc herniation. Spine (Phila Pa 1976) 33, 2034-2040. (doi:10. 1097/BRS. 0b013e31817eb872)
91. Smith LJ, Chiaro JA, Nerurkar NL, Cortes DH, Horava SD, Hebela NM, Mauck RL, Dodge GR, Elliott DM. 2011 Nucleus pulposus cells synthesize a functional extracellular matrix and respond to inflammatory cytokine challenge following long-term agarose culture. Eur. Cell Mater. 22, 291-301.
92. Hoyland JA, Le Maitre C, Freemont AJ. 2008 Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxf.) 47, 809-814. (doi:10. 1093/rheumatology/ ken056)
93. Seguin CA, Pilliar RM, Roughley PJ, Kandel RA. 2005 Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976) 30, 1940-1948. (doi:10. 1097/01. brs. 0000176188. 40263. f9)
94. Seguin CA, Pilliar RM, Madri JA, Kandel RA. 2008 TNF-alpha induces MMP2 gelatinase activity and MT1-MMP expression in an in vitro model of nucleus pulposus tissue degeneration. Spine (Phila Pa 1976) 33, 356-365. (doi:10. 1097/BRS. 0b013e3181642a5e)
95. Gawri R, Rosenzweig DH, Krock E, Ouellet JA, Stone LS, Quinn TM, Haglund L. 2014 High mechanical strain of primary intervertebral disc cells promotes secretion of inflammatory factors associated with disc degeneration and pain. Arthritis Res. Ther. 16, R21. (doi:10. 1186/ar4449)
96. Walter BA, Korecki CL, Purmessur D, Roughley PJ, Michalek AJ, Iatridis JC. 2011 Complex loading affects intervertebral disc mechanics and biology. Osteoarthritis Cartilage 19, 1011-1018. (doi:10. 1016/j. joca. 2011. 04. 005)
97. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MTN, Ross ERS, O'Brien JPJ, Hoyland A. 2002 Nerve growth factor expression and innervation of the painful intervertebral disc. J. Pathol. 197, 286-292. (doi:10. 1002/ path. 1108)
98. Melrose J, Roberts S, Smith S, Menage J, Ghosh P. 2002 Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine (Phila Pa 1976) 27, 1278-1285. (doi:10. 1097/00007632-20020 6150-00007)
99. Kawakami M, Weinstein JN, Chatani K, Spratt KF, Meller ST, Gebhart GF. 1994 Experimental lumbar radiculopathy. Behavioral and histologic changes in a model of radicular pain after spinal nerve root irritation with chromic gut ligatures in the rat. Spine (Phila Pa 1976) 19, 1795-1802. (doi:10. 1097/ 00007632-199408150-00002)
100. Olmarker K, Blomquist J, Stromberg J, Nannmark U, Thomsen P, Rydevik B. 1995 Inflammatogenic properties of nucleus pulposus. Spine (Phila Pa 1976) 20, 665-669. (doi:10. 1097/00007632-199503150-00006)
101. Lotz JC, Ulrich JA. 2006 Innervation, inflammation, and hypermobility may characterize pathologic disc degeneration: review of animal model data. J. Bone Joint Surg. Am. 88(Suppl. 2), 76-82. (doi:10. 2106/ JBJS. E. 01448)
102. Kobayashi S et al. 2009 Ultrastructural analysis on lumbar disc herniation using surgical specimens: role of neovascularization and macrophages in hernias. Spine (Phila Pa 1976) 34, 655-662. (doi:10. 1097/BRS. 0b013e31819c9d5b)
103. Ahn SH, Ahn MW, Byun WM. 2000 Effect of the transligamentous extension of lumbar disc herniations on their regression and the clinical outcome of sciatica. Spine (Phila Pa 1976) 25, 475-480. (doi:10. 1097/00007632-20000 2150-00014)
104. Ikeda T, Nakamura T, Kikuchi T, Umeda S, Senda H, Takagi K. 1996 Pathomechanism of spontaneous regression of the herniated lumbar disc: histologic and immunohistochemical study. J. Spinal Disord. 9, 136-140. (doi:10. 1097/00002517-199604000-00009)
105. Gezici AR, Ergun R. 2009 Spontaneous regression of a huge subligamentous extruded disc herniation: short report of an illustrative case. Acta Neurochir. (Wien) 151, 1299-1300. (doi:10. 1007/s00701-009-0370-x)
106. Takada T, Nishida K, Maeno K, Kakutani K, Yurube T, Doita M, Kurosaka M. 2012 Intervertebral disc and macrophage interaction induces mechanical hyperalgesia and cytokine production in a herniated disc model in rats. Arthritis Rheum. 64, 2601-2610. (doi:10. 1002/art. 34456)
107. Matsui Y, Maeda M, Nakagami W, Iwata H. 1998 The involvement of matrix metalloproteinases and inflammation in lumbar disc herniation. Spine (Phila Pa 1976) 23, 863-868; discussion 868-869. (doi:10. 1097/00007632-199804150-00005)
108. Murai K, Sakai D, Nakamura Y, Nakai T, Igarashi T, Seo N, Murakami T, Kobayashi E, Mochida J. 2010 Primary immune system responders to nucleus pulposus cells: evidence for immune response in disc herniation. Eur. Cell Mater. 19, 13-21.
109. Wang H et al. 2013 Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration. J. Biol. Chem. 288, 16 761-16 774. (doi:10. 1074/ jbc. M112. 446633)
110. Kepler CK, Markova DZ, Dibra F, Yadla S, Vaccaro AR, Risbud MV, Albert TJ, Anderson DG. 2013 Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1beta in painful human intervertebral discs. Spine (Phila Pa 1976) 38, 873-880. (doi:10. 1097/BRS. 0b013e318 285ae08)
111. Le Maitre C, Hoyland J, Freemont A. 2007 Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res. Ther. 9, R77. (doi:10. 1186/ar2275)
112. Le Maitre CL, Freemont AJ, Hoyland JA. 2005 The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res. Ther. 7, R732-R745. (doi:10. 1186/ar1732)
113. Abe Y, Akeda K, An HS, Aoki Y, Pichika R, Muehleman C, Kimura T, Masuda K. 2007 Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells. Spine (Phila Pa 1976) 32, 635-642. (doi:10. 1097/01. brs. 0000257556. 90850. 53)
114. Miyahara K, Ishida T, Hukuda S, Horiike K, Okamoto M, Tojo H. 1996 Human group II phospholipase A2 in normal and diseased intervertebral discs. Biochim. Biophys. Acta 1316, 183-190. (doi:10. 1016/0925-4439(96)00023-3)
115. Wang J et al. 2013 Tumor necrosis factor alpha-and interleukin-1beta-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis Rheum. 65, 832-842. (doi:10. 1002/art. 37819)
116. Kokubo Y et al. 2008 Herniated and spondylotic intervertebral discs of the human cervical spine: histological and immunohistological findings in 500 en bloc surgical samples. Laboratory investigation. J. Neurosurg. Spine 9, 285-295. (doi:10. 3171/SPI/ 2008/9/9/285)
117. Takahashi H, Suguro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T. 1996 Inflammatory cytokines in the herniated disc of the lumbar spine. Spine (Phila Pa 1976) 21, 218-224. (doi:10. 1097/00007632-199601150-00011)
118. Kang JD, Georgescu HI, Mcintyre-Larkin L, Stefanovic-Racic M, Donaldson III WF, Evans CH. 1996 Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) 21, 271-277. (doi:10. 1097/ 00007632-199602010-00003)
119. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS. 2002 mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976) 27, 911-917. (doi:10. 1097/ 00007632-200205010-00005)
120. Henriksson H, Thornemo M, Karlsson C, Hägg O, Junevik K, Lindahl A, Brisby H. 2009 Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine 34, 2278-2287. (doi:10. 1097/BRS. 0b013e3181a95ad2)
121. Miyamoto H, Saura R, Harada T, Doita M, Mizuno K. 2000 The role of cyclooxygenase-2 and inflammatory cytokines in pain induction of herniated lumbar intervertebral disc. Kobe J. Med. Sci. 46, 13-28.
122. Shamji MF et al. 2010 Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 62, 1974-1982. (doi:10. 1002/art. 27444)
123. Zhang W, Nie L, Wang Y, Wang X, Zhao H, Dongol S, Maharjan S, Cheng L. 2013 CCL20 secretion from the nucleus pulposus improves the recruitment of CCR6-expressing Th17 cells to degenerated IVD tissues. PLoS ONE 8, e66286. (doi:10. 1371/journal. pone. 0066286)
124. Kim JH, Studer RK, Sowa GA, Vo NV, Kang JD. 2008 Activated macrophage-like THP-1 cells modulate anulus fibrosus cell production of inflammatory mediators in response to cytokines. Spine (Phila Pa 1976) 33, 2253-2259. (doi:10. 1097/BRS. 0b013e318182c35f)
125. Park JY, Kuh SU, Park HS, Kim KS. 2011 Comparative expression of matrix-associated genes and inflammatory cytokines-associated genes according to disc degeneration: analysis of living human nucleus pulposus. J. Spinal Disord. Tech. 24, 352-357. (doi:10. 1097/BSD. 0b013e3181fee4df)
126. Kepler CK, Markova DZ, Hilibrand AS, Vaccaro AR, Risbud MV, Albert TJ, Anderson DG. 2013 Substance P stimulates production of inflammatory cytokines in human disc cells. Spine (Phila Pa 1976) 38, E1291-E1299. (doi:10. 1097/BRS. 0b013e3182a42bc2)
127. Burke JG, Rw GW, Conhyea D, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. 2003 Human nucleus pulposis can respond to a pro-inflammatory stimulus. Spine (Phila Pa 1976) 28, 2685-2693. (doi:10. 1097/01. BRS. 0000103341. 45133. F3)
128. Kim JH, Studer RK, Vo NV, Sowa GA, Kang JD. 2009 p38 MAPK inhibition selectively mitigates inflammatory mediators and VEGF production in AF cells co-cultured with activated macrophage-like THP-1 cells. Osteoarthritis Cartilage 17, 1662-1669. (doi:10. 1016/j. joca. 2009. 06. 004)
129. Sinclair SM, Shamji MF, Chen J, Jing L, Richardson WJ, Brown CR, Fitch RD, Setton LA. 2011 Attenuation of inflammatory events in human intervertebral disc cells with a tumor necrosis factor antagonist. Spine (Phila Pa 1976) 36, 1190-1196. (doi:10. 1097/BRS. 0b013e3181ebdb43)
130. Studer RK, Vo N, Sowa G, Ondeck C, Kang J. 2011 Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-alpha. Spine (Phila Pa 1976) 36, 593-599. (doi:10. 1097/BRS. 0b013e3181da38d5)
131. Tian Y, Yuan W, Fujita N, Wang J, Wang H, Shapiro IM, Risbud MV. 2013 Inflammatory cytokines associated with degenerative disc disease control aggrecanase-1 (ADAMTS-4) expression in nucleus pulposus cells through MAPK and NF-kappaB. Am. J. Pathol. 182, 2310-2321. (doi:10. 1016/j. ajpath. 2013. 02. 037)
132. Yu ZG, Xu N, Wang WB, Pan SH, Li KS, Liu JK. 2009 Interleukin-1 inhibits Sox9 and collagen type II expression via nuclear factor-kappaB in the cultured human intervertebral disc cells. Chin. Med. J. (Engl.) 122, 2483-2488.
133. Doita M, Kanatani T, Harada T, Mizuno K. 1996 Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine (Phila Pa 1976) 21, 235-241. (doi:10. 1097/00007632-199601150-00015)
134. Bachmeier BE, Nerlich AG, Weiler C, Paesold G, Jochum M, Boos N. 2007 Analysis of tissue distribution of TNF-a, TNF-a-receptors, and the activating TNF-a-converting enzyme suggests activation of the TNF-a system in the aging intervertebral disc. Ann. NY Acad. Sci. 1096, 44-54. (doi:10. 1196/annals. 1397. 069)
135. Risbud MV, Shapiro IM. 2014 Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat. Rev. Rheumatol. 10, 44-56. (doi:10. 1038/nrrheum. 2013. 160)
136. Goupille P, Mulleman D, Paintaud G, Watier H, Valat JP. 2007 Can sciatica induced by disc herniation be treated with tumor necrosis factor alpha blockade? Arthritis Rheum. 56, 3887-3895. (doi:10. 1002/ art. 23051)
137. Purmessur D, Walter BA, Roughley PJ, Laudier DM, Hecht AC, Iatridis J. 2013 A role for TNFalpha in intervertebral disc degeneration: a non-recoverable catabolic shift. Biochem. Biophys. Res. Commun. 433, 151-156. (doi:10. 1016/j. bbrc. 2013. 02. 034)
138. Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. 2007 Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem. Soc. Trans. 35, 652-655. (doi:10. 1042/ BST0350652)
139. Igarashi T, Kikuchi S, Shubayev V, Myers RR. 2000 Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology: molecular, histologic, and behavioral comparisons in rats. Spine 25, 2975-2980. (doi:10. 1097/00007632-200012010-00003)
140. Kauppila LI. 1995 Ingrowth of blood vessels in disc degeneration. Angiographic and histological studies of cadaveric spines. J. Bone Joint Surg. Am. 77, 26-31.
141. Hess A et al. 2011 Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc. Natl Acad. Sci. USA 108, 3731-3736. (doi:10. 1073/pnas. 1011774108)
142. Cuellar JM, Borges PM, Cuellar VG, Yoo A, Scuderi GJ, Yeomans DC. 2012 Cytokine expression in the epidural space: a model of non-compressive disc herniation-induced inflammation. Spine (Phila Pa 1976) 38, 17-23. (doi:10. 1097/BRS. 0b013e3182604baa)
143. Rousseau MA, Ulrich JA, Bass EC, Rodriguez AG, Liu JJ, Lotz JC. 2007 Stab incision for inducing intervertebral disc degeneration in the rat. Spine (Phila Pa 1976) 32, 17-24. (doi:10. 1097/01. brs. 0000251013. 07656. 45)
144. Anderson DG, Izzo MW, Hall DJ, Vaccaro AR, Hilibrand A, Arnold W, Tuan RS, Albert TJ. 2002 Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976) 27, 1291-1296. (doi:10. 1097/00007632-2002 06150-00009)
145. Sobajima S, Kompel JF, Kim JS, Wallach CJ, Robertson DD, Vogt MT, Kang JD, Gilbertson LG. 2005 A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine (Phila Pa 1976) 30, 15-24. (doi:10. 1097/ 00007632-200511150-00023)
146. Baggiolini M, Dewald B, Moser B. 1997 Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705. (doi:10. 1146/annurev. immunol. 15. 1. 675)
147. Yoshida M, Nakamura T, Sei A, Kikuchi T, Takagi K, Matsukawa A. 2005 Intervertebral disc cells produce tumor necrosis factor alpha, interleukin-1beta, and monocyte chemoattractant protein-1 immediately after herniation: an experimental study using a new hernia model. Spine (Phila Pa 1976) 30, 55-61. (doi:10. 1097/01. brs. 0000149194. 17891. bf)
148. O'Neill CW, Liu JJ, Leibenberg E, Hu SS, Deviren V, Tay BK-B, Chin CT, Lotz JC. 2004 Percutaneous plasma decompression alters cytokine expression in injured porcine intervertebral discs. Spine J. 4, 88-98. (doi:10. 1016/S1529-9430 (03)00423-6)
149. Rajan N, Bloom O, Maidhof R, Stetson N, Sherry B, Levine M, Chahine NO. 2012 Toll-like receptor 4 (TLR4) expression and stimulation in a model of intervertebral disc inflammation and degeneration. Spine (Phila Pa 1976) 38, 1343-1351. (doi:10. 1097/BRS. 0b013e31826b71f4)
150. Morimoto R, Akeda K, Iida R, Nishimura A, Tsujii M, Obata S, Kasai Y, Uchida A, Sudo A. 2012 Tissue renin-angiotensin system in the intervertebral disc. Spine (Phila Pa 1976) 38, E129-E136. (doi:10. 1097/BRS. 0b013e31827b8c89)
151. Gruber HE, Hanley Jr EN. 2002 Ultrastructure of the human intervertebral disc during aging and degeneration: comparison of surgical and control specimens. Spine (Phila Pa 1976) 27, 798-805. (doi:10. 1097/00007632-200204150-00004)
152. Bach FC, Willems N, Penning LC, Ito K, Meij BP, Tryfonidou MA. 2014 Potential regenerative treatment strategies for intervertebral disc degeneration in dogs. BMC Vet. Res. 10, 3. (doi:10. 1186/1746-6148-10-3)
153. Bergknut N et al. 2013 Intervertebral disc disease in dogs-part 1: a new histological grading scheme for classification of intervertebral disc degeneration in dogs. Vet. J. 195, 156-163. (doi:10. 1016/j. tvjl. 2012. 05. 027)
154. Alini M et al. 2008 Are animal models useful for studying human disc disorders/degeneration? Eur. Spine J. 17, 2-19. (doi:10. 1007/s00586-007-0414-y)
155. Roberts S, Butler RC. 2005 Inflammatory mediators as potential therapeutic targets in the spine. Curr. Drug Targets 4, 257-266. (doi:10. 2174/1568010 053586372).
156. Wuertz K, Vo N, Kletsas D, Boos N. 2012 Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-kappaB and MAP kinases. Eur. Cell Mater. 23, 103-119; discussion 119-120.
157. Genevay S, Viatte S, Finckh A, Zufferey P, Balague F, Gabay C. 2010 Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62, 2339-2346. (doi:10. 1002/art. 27499)
158. Genevay S, Stingelin S, Gabay C. 2004 Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann. Rheum. Dis. 63, 1120-1123. (doi:10. 1136/ard. 2003. 016451)
159. Olmarker K, Rydevik B. 2001 Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine (Phila Pa 1976) 26, 863-869. (doi:10. 1097/00007632-200104150-00007)
160. Okoro T, Tafazal SI, Longworth S, Sell PJ. 2010 Tumor necrosis alpha-blocking agent (etanercept): a triple blind randomized controlled trial of its use in treatment of sciatica. J. Spinal Disord. Tech. 23, 74-77. (doi:10. 1097/BSD. 0b013e3 1819afdc4)
161. Muller-Ladner U, Roberts CR, Franklin BN, Gay RE, Robbins PD, Evans CH, Gay S. 1997 Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J. Immunol. 158, 3492-3498.
162. Autio RA, Karppinen JNiinimäki J, Ojala R, Veeger N, Korhonen T, Hurri H, Tervonen O. 2006 The effect of infliximab, a monoclonal antibody against TNF-a, on disc herniation resorption: a randomized controlled study. Spine 31, 2641-2645. (doi:10. 1097/01. brs. 0000244616. 64962. 9e)
163. Tobinick E. 2006 Spinal delivery of p38: TNF-alpha inhibitors. PLoS Med. 3, e511. (doi:10. 1371/journal. pmed. 0030511)
164. Ragab AA, Woodall Jr JW, Tucci MA, Wingerter SA, Fosnaugh AW, Franklin LN, Benghuzzi HA. 2009 A preliminary report on the effects of sustained administration of corticosteroid on traumatized disc using the adult male rat model. J. Spinal Disord. Tech. 22, 473-478. (doi:10. 1097/BSD. 0b013e318 18d5e55)
165. Zhang H, Wang L, Park JB, Park P, Yang VC, Hollister SJ, La Marca F, Lin C-Y. 2009 Intradiscal injection of simvastatin retards progression of intervertebral disc degeneration induced by stab injury. Arthritis Res. Ther. 11, R172. (doi:10. 1186/ ar2861)
166. Gorth DJ, Mauck RL, Chiaro JA, Mohanraj B, Hebela NM, Dodge GR, Elliott DM, Smith LJ. 2012 IL-1ra delivered from poly(lactic-co-glycolic acid) microspheres attenuates IL-1b-mediated degradation of nucleus pulposus in vitro. Arthritis Res. Ther. 14, R179. (doi:10. 1186/ar3932)
167. Kawakami M, Matsumoto T, Hashizume H, Kuribayashi K, Tamaki T. 2002 Epidural injection of cyclooxygenase-2 inhibitor attenuates painrelated behavior following application of nucleus pulposus to the nerve root in the rat. J. Orthop. Res. 20, 376-381. (doi:10. 1016/S0736-0266(01) 00114-0)
168. Nagae M et al. 2007 Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng. 13, 147-158. (doi:10. 1089/ten. 2006. 0042)
169. Wu C-C, Chen W-H, Zao B, Lai P-L, Lin T-C, Lo H-Y, Shieh Y-H, Wu C-H, Deng W-P. 2011 Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokineinhibited chondrogenesis. Biomaterials 32, 5847-5854. (doi:10. 1016/j. biomaterials. 2011. 05. 002)
170. Wuertz K, Quero L, Sekiguchi M, Klawitter M, Nerlich A, Konno S, Kikuchi S, Boos N. 2011 The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposusmediated pain in vitro and in vivo. Spine 36, 1373-1384. (doi:10. 1097/BRS. 0b013e318221e655)
171. Li H, Liang C, Chen Q, Yang Z. 2011 Rhein: a potential biological therapeutic drug for intervertebral disc degeneration. Med. Hypotheses 77, 1105-1107. (doi:10. 1016/j. mehy. 2011. 09. 013)
172. Liu Q, Jin L, Shen FH, Balian G, Li XJ. 2013 Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells-a potential novel treatment for intervertebral disc degeneration. Spine J. 13, 1571-1580. (doi:10. 1016/j. spinee. 2013. 04. 004)
173. Kobori S et al. 2014 Inhibiting IkappaB kinase-beta downregulates inflammatory cytokines in injured discs and neuropeptides in dorsal root ganglia innervating injured discs in rats. Spine (Phila Pa 1976) 39, 1171-1177. (doi:10. 1097/BRS. 000000 0000000374)
174. Vadalà G, Sowa GA, Kang JD. 2007 Gene therapy for disc degeneration. Expert Opin. Biol. Ther. 7, 185-196 (doi:10. 1517/14712598. 7. 2. 185)
175. Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino JA, Herzog R. 2009 2009 ISSLS prize winner: does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine (Phila Pa 1976) 34, 2338-2345. (doi:10. 1097/BRS. 0b013e3181ab5432)
176. Vadala G, Russo F, Pattappa G, Schiuma D, Peroglio M, Benneker LM, Grad S, Alini M, Denaro V. 2013 The transpedicular approach as an alternative route for intervertebral disc regeneration. Spine (Phila Pa 1976) 38, E319-E324. (doi:10. 1097/BRS. 0b013e3 18285bc4a)
177. Gibson MJ, Karpinski MR, Slack RC, Cowlishaw WA, Webb JK. 1987 The penetration of antibiotics into the normal intervertebral disc. J. Bone Joint Surg. Br. 69, 784-786.
178. Motaghinasab S, Shirazi-Adl A, Urban JP, Parnianpour M. 2012 Computational pharmacokinetics of solute penetration into human intervertebral discs-effects of endplate permeability, solute molecular weight and disc size. J. Biomech. 45, 2195-2202. (doi:10. 1016/j. jbiomech. 2012. 06. 033)
179. Ferguson SJ, Ito K, Nolte LP. 2004 Fluid flow and convective transport of solutes within the intervertebral disc. J. Biomech. 37, 213-221. (doi:10. 1016/S0021-9290(03)00250-1)
180. Wehling P, Schulitz KP, Robbins PD, Evans CH, Reinecke JA. 1997 Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine 15, 1092-1097. (doi:10. 1097/00007632-199705150-00008)
181. Le Maitre CL, Hoyland JA, Freemont AJ. 2007 Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res. Ther. 9, R83. (doi:10. 1186/ar2282)
182. Nishida K, Kang JD, Gilbertson LG, Moon S-H, Suh JK, Vogt MT, Robbins PD, Evans CH. 1999 Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) 24, 2419-2425. (doi:10. 1097/00007632-199912010-00002)
183. Lee YJ, Kong MH, Song KY, Lee KH, Heo SH. 2008 The relation between Sox9, TGF-b1, and proteoglycan in human intervertebral disc cells. J. Kor. Neurosurg. Soc. 43, 149-154. (doi:10. 3340/ jkns. 2008. 43. 3. 149)
184. Tan Y, Hu Y, Tan J. 2003 Extracellular matrix synthesis and ultrastructural changes of degenerative disc cells transfected by Ad/CMV-hTGFbeta. Chin. Med. J. (Engl.) 116, 1399-1403.
185. Leckie S et al. 2012 Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine 12, 7-20. (doi:10. 1016/j. spinee. 2011. 09. 011)
186. Haufe SMW, Mork AR. 2006 Intradiscal injection of hematopoietic stem cells in an attempt to rejuvenate the intervertebral discs. Stem Cells Dev. 15, 136-137. (doi:10. 1089/scd. 2006. 15. 136)
187. Quintin A, Schizas C, Scaletta C, Jaccoud S, Gerber S, Osterheld MC, Juillerat L, Applegate LA, Pioletti DP. 2008 Isolation and in vitro chondrogenic potential of human foetal spine cells. J. Cell Mol. Med. 13, 2559-2569. (doi:10. 1111/j. 1582-4934. 2008. 00630. x)
188. Iwashina T, Mochida J, Sakai D, Yamamoto Y, Miyazaki T, Ando K, Hotta T. 2006 Feasibility of using a human nucleus pulposus cell line as a cell source in cell transplantation therapy for intervertebral disc degeneration. Spine 31, 1177-1186. (doi:10. 1097/01. brs. 0000217687. 36874. c4)
189. Hohaus C, Ganey TM, Minkus Y, Meisel HJ. 2008 Cell transplantation in lumbar spine disc degeneration disease. Eur. Spine J. 17(Suppl. 4), S492-S503. (doi:10. 1007/s00586-008-0750-6)
190. Sheikh H, Zakharian K, De La Torre RP, Facek C, Vasquez A, Chaudhry GR, Svinarich D, Peter-Cruet MJ. 2009 In vivo intervertebral disc regeneration using stem cell-derived chondroprogenitors: laboratory investigation. J. Neurosurg. 10, 265-272. (doi:10. 3171/2008. 12. SPINE0835)
191. Chen J, Lee EJ, Jing L, Christoforou N, Leong KW, Setton LA. 2013 Differentiation of mouse induced pluripotent stem cells (iPSCs) into nucleus pulposus-like cells in vitro. PLoS ONE 8, e75548. (doi:10. 1371/journal. pone. 0075548)
192. Murrell W, Sanford E, Anderberg L, Cavanagh B, Mackay-Sim A. 2009 Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Spine J. 9, 585-594. (doi:10. 1016/j. spinee. 2009. 02. 011)
193. Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T. 2005 Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 30, 2379-2387. (doi:10. 1097/01. brs. 0000184365. 28481. e3)
194. Chon BH, Lee EJ, Jing L, Setton LA, Chen J. 2013 Human umbilical cord mesenchymal stromal cells exhibit immature nucleus pulposus cell phenotype in a laminin-rich pseudo-three-dimensional culture system. Stem Cell Res. Ther. 4, 120. (doi:10. 1186/ scrt331)
195. Erwin WM, Islam D, Eftekarpour E, Inman RD, Karim MZ, Fehlings MG. 2013 Intervertebral disc-derived stem cells: implications for regenerative medicine and neural repair. Spine 38, 211-216. (doi:10. 1097/BRS. 0b013e318266a80d)
196. Kim JH, Moon HJ, Lee JH, Kim JH, Kwon TH, Park YK. 2012 Rabbit notochordal cells modulate the expression of inflammatory mediators by human annulus fibrosus cells cocultured with activated macrophage-like THP-1 cells. Spine (Phila Pa 1976) 37, 1856-1864. (doi:10. 1097/BRS. 0b013e3182579434)
197. Serigano K, Sakai D, Hiyama A, Tamura F, Tanaka M, Mochida J. 2010 Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model. J. Orthop. Res. 28, 1267-1275. (doi:10. 1002/jor. 21147)
198. Miyamoto T, Muneta T, Tabuchi T, Matsumoto K, Saito H, Tsuji K, Sekiya I. 2010 Intradiscal transplantation of synovial mesenchymal stem cells prevents intervertebral disc degeneration through suppression of matrix metalloproteinase-related genes in nucleus pulposus cells in rabbits. Arthritis Res. Ther. 12, R206. (doi:10. 1186/ar3182)
199. Yoo K et al. 2009 Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 259, 150-156. (doi:10. 1016/j. cellimm. 2009. 06. 010)
200. Prockop DJ, Oh JY. 2012 Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol. Ther. 20, 14-20. (doi:10. 1038/mt. 2011. 211)
201. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. 2007 Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl Acad. Sci. USA 104, 11 002-11 007. (doi:10. 1073/pnas. 0704421104)
202. Lee RH et al. 2009 Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the antiinflammatory protein TSG-6. Cell Stem Cell 5, 54-63. (doi:10. 1016/j. stem. 2009. 05. 003)
203. Oh JY, Roddy GW, Choi H, Lee RH, Ylostalo JH, Rosa RH, Prockop DJ. 2010 Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc. Natl Acad. Sci. USA 107, 16 875-16 880. (doi:10. 1073/ pnas. 1012451107)
204. Hiyama A, Mochida J, Iwashina T, Omi H, Watanabe T, Serigano K, Tamura F, Sakai D. 2008 Transplantation of mesenchymal stem cells in a canine disc degeneration model. J. Orthop. Res. 26, 589-600. (doi:10. 1002/jor. 20584)
205. Bertolo A, Thiede T, Aebli N, Baur M, Ferguson S, Stoyanov J. 2011 Human mesenchymal stem cell co-culture modulates the immunological properties of human intervertebral disc tissue fragments in vitro. Eur. Spine J. 20, 592-603. (doi:10. 1007/ s00586-010-1662-9)
206. Orozco L, Soler R, Morera C, Alberca M, Sanchez A, Garcá-Sancho J. 2011 Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation 92, 822-828. (doi:10. 1097/ TP. 0b013e3182298a15)
207. Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y. 2010 Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine 35, E475-E480. (doi:10. 1097/BRS. 0b013e3181cd2cf4)
208. Pang X, Yang H, Peng B. 2014 Human umbilical cord mesenchymal stem cell transplantation for the treatment of chronic discogenic low back pain. Pain Phys. 17, E525-E530.
209. Pettine KA, Murphy MB, Suzuki RK, Sand TT. 2014 Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells 33, 146-156. (doi:10. 1002/stem. 1845)
210. Meirelles L, Fontes AM, Covas DT, Caplan AI. 2009 Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytok. Growth Factor Rev. 20, 419-427. (doi:10. 1016/j. cytogfr. 2009. 10. 002)
211. Karp JM, Leng Teo GS. 2009 Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4, 206-216. (doi:10. 1016/j. stem. 2009. 02. 001)
212. Ponte A, Marais E, Gallay N, Langonne A, Delorme B, Herault E, Charboard P, Domenech J. 2009 The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737-1745. (doi:10. 1634/stemcells. 2007-0054)
213. Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D, Lagneaux L. 2009 In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 11, 559-569. (doi:10. 1080/ 14653240903051541)
214. Illien-Jünger SPG, Peroglio M, Benneker LM, Stoddart MJ, Sakai D, Mochida J, Grad S, Alini M. 2012 Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine 37, 1865-1873. (doi:10. 1097/ BRS. 0b013e3182544a8a)
215. Pattappa G, Peroglio M, Sakai D, Mochida J, Benneker LM, Alini M, Grad S. 2014 CCL5/RANTES is a key chemoattractant released by degenerative intervertebral discs in organ culture. Eur. Cell Mater. 27, 124-136; discussion 136.
216. Pereira CL et al. 2014 The effect of hyaluronanbased delivery of stromal cell-derived factor-1 on the recruitment of MSCs in degenerating intervertebral discs. Biomaterials 35, 8144-8153. (doi:10. 1016/j. biomaterials. 2014. 06. 017)
217. Henriksson H, Svala E, Skioldebrand E, Lindahl AMD, Brisby H. 2012 Support of concept that migrating progenitor cells from stem cell niches contribute to normal regeneration of the adult mammal intervertebral disc. Spine 37, 722-732. (doi:10. 1097/BRS. 0b013e318231c2f7)
218. Claes L, Recknagel S, Ignatius A. 2012 Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 8, 133-143. (doi:10. 1038/ nrrheum. 2012. 1)
219. Mountziaris PM, Spicer PP, Kasper FK, Mikos AG. 2011 Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng. B 17, 393-402. (doi:10. 1089/ten. teb. 2011. 0182)
220. Boccafoschi F, Mosca C, Cannas M. 2012 Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality? J. Tissue Eng. Regen. Med. 8, 253-267. (doi:10. 1002/term. 1526)
221. Torres AL, Santos SG, Oliveira MI, Barbosa MA. 2013 Fibrinogen promotes resorption of chitosan by human osteoclasts. Acta Biomater. 9, 6553-6562. (doi:10. 1016/j. actbio. 2013. 01. 015)
222. Almeida CR, Vasconcelos DP, Goncalves RM, Barbosa MA. 2012 Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials. J. R. Soc. Interface 9, 261-271. (doi:10. 1098/rsif. 2011. 0357)
223. Oliveira MI, Santos SG, Oliveira MJ, Torres AL, Barbosa MA. 2012 Chitosan drives antiinflammatory macrophage polarisation and proinflammatory dendritic cell stimulation. Eur. Cell Mater. 24, 136-152; discussion 152-153.
224. Maciel J, Oliveira MI, Colton E, McNally AK, Oliveira C, Anderson JM, Barbosa MA. 2014 Adsorbed fibrinogen enhances production of bone-and angiogenic-related factors by monocytes/ macrophages. Tissue Eng. A 20, 250-263. (doi:10. 1089/ten. tea. 2012. 0439)
225. Lee J, Sayed N, Hunter A, Au KF,, Wong WH, Mocarski ES, Pera RR, Yakubov E, Cooke JP. 2012 Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151, 547-558. (doi:10. 1016/j. cell. 2012. 09. 034)
226. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda M, Yamanaka S. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (doi:10. 1016/j. cell. 2007. 11. 019)
227. O'Neill LAJ. 2012 Transflammation: when innate immunity meets induced pluripotency. Cell 151, 471-473. (doi:10. 1016/j. cell. 2012. 10. 006)
228. Raghow R. 1994 The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8, 823-831.